|
Sponsored by:
|
Citigroup (C) |
Yahoo (YHOO) |
Dow Chemical (DOW) |
Netflix (NFLX) |
Apple (AAPL) |
Focus Stocks
CVS Caremark Expecting Resistance Soon?
Published on Friday, 03 September 2010 04:24 Written by Christian Paolinetti
New York, September 3rd (TradersHuddle.com) - Shares of CVS Caremark Corporation (NYSE:CVS) closed the trading session at $28.31 near its 50 day moving average currently set at $29.54. CVS' price action is below this important level, which makes the stock difficult to buy, as there will certainly be resistance as it approaches its 50 day.
CVS Caremark Corporation (NYSE:CVS) is a pharmacy services company that operates a chain of drugstores located throughout the United States. The stores offer a wide range of branded and generic drugs, as well as household goods. The Pharmacy Service segment provides a range of prescription benefit management services, including mail order pharmacy services, specialty pharmacy services, plan design and administration, formulary management, and claims processing.
Latest price action range, defined by a peaks and troughs algorithm places calculated support at $26.84 and calculated resistance at $32.09. These levels will be closely watched by traders, as they provide great insight into the latest price dynamics defined by CVS Caremark shares.
Traders should evaluate their trade if they want to establish a position on CVS Caremark given the resistance expected as the stock approaches the 50 day moving average. A trade might materialize as the stock manages to break this important level, as it could be used as support going forward, however until the break materializes buying the stock is nothing different than flipping a coin. Other levels that traders will be evaluating are the ones defined by the peak and troughs algorithm that provides great price level reference points.
Related Articles
- Shopping For A Deal
- CVS Caremark Appoints New Senior Vice President of Government Affairs
- Critical Alerts for CVS Caremark, UPS, Humana, AOL, and Manpower Released by Seven Summits Research
- CVS/pharmacy Helps Customers Save Time with New Prescription Text Alerts
- CVS Caremark Corporation to Hold Fourth Quarter 2011 Conference Call
- A 52 Week High for CVS Caremark, will it Hold?
- CVS/pharmacy Launches Enhanced "Send to Card" Digital Options for Redeeming ExtraBucks® Rewards
- CVS Caremark Bulls in Charge
- FTC Ends Investigation of CVS Caremark
- CVS Caremark Executive Outlines Integrated Pharmacy-Based Program At Health Affairs Forum on Diabetes
Related Partner Headlines
- CVS Caremark Stock Hits New 52-Week High (CVS) - TheStreet.com
- How to Shop a Drugstore - TheStreet.com
- CVS Caremark Stock To Go Ex-dividend Tomorrow (CVS) - TheStreet.com
- CVS Caremark Stock Hits New 52-Week High (CVS) - TheStreet.com
- Market Morning: ECB in Spotlight - TheStreet.com
- CVS Caremark Reaches New 52-Week High (CVS) - TheStreet.com
- 3 Health Care Buys for 2012 - TheStreet.com
- 6 'Slam-Dunk' Stocks for 2012 -- and a Decade Beyond - TheStreet.com
- CVS Caremark Stock Hits New 52-Week High (CVS) - TheStreet.com
- CVS Sees 2012 Profit Bump, Lifts Dividend - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Recent Trading Ideas
-
Oil States Breaking Out? -
Trading Idea - Buffalo Wild Wings Breaking Out? -
Google Approaching its 50 Day -
Paychex Close to 50 Day Moving Average -
Closing in to Support? -
Approaching Resistance - Netflix -
Carnival Expecting Resistance Soon? -
Trading Idea - Pioneer Natural Resources Broke Resistance, What to Expect? -
Playing the Setup in Willis Group -
Trading Idea - Franklin Resources Breaking Out? -
Trading Idea - Donaldson Broke Resistance, What to Expect? -
Quiksilver Broke Resistance
Latest Partner Headlines
-
Facebook's IPO Fortune: Tech Weekly Recap - TheStreet.com -
Private Equity Has a 'Social Responsibility': Carlyle Founder - TheStreet.com -
Foreclosure Settlement Will Settle Nothing - TheStreet.com -
Benzinga's Top ETF Decliners, February 3rd - Benzinga -
Benzinga's Top ETF Gainers, February 3rd - Benzinga -
'Mad Money Lightning Round': Kraft Foods Heading Higher - TheStreet.com -
Falling Earnings Hit Goldman CEO Blankfein's Pay - TheStreet.com -
Research In Motion's Dangerous Waiting Game - TheStreet.com -
Cramer's 'Mad Money' Recap: Next Week's Game Plan (Update 1) - TheStreet.com -
Benzinga's M&A Chatter for Friday February 3, 2012 - Benzinga
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,862.23 Trade time:4:03PM EST Value change:▲156.82 (1.23%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,344.90 Trade time:4:33PM EST Value change:▲19.36 (1.46%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,905.66 Trade time:5:16PM EST Value change:▲45.98 (1.61%)In The Wires
-
Vicks® NyQuil® and Vicks DayQuil® Reveal the NFL Player Least Likely to Take a Sick Day on Super Bowl XLVI -
Colorado’s Fresh Snow Brings Low Fares on Frontier Airlines -
SGOCO Group, Ltd. Relocates Corporate Headquarters to Beijing -
SGOCO Group, Ltd. Receives NASDAQ Deficiency Notification -
Security Bank of California Completes the Acquisition of Its Orange Office -
Record Earnings Announced by County Commerce Bank for 4th Quarter 2011 -
Cardinal Health Statement Regarding Temporary Restraining Order to Avoid Disruption in Controlled Medicine Shipments From Florida -
Bank of Santa Clarita Reports Record Pre-Tax Earnings -
Faruqi & Faruqi, LLP Files Securities Class Action Suit Against China Medical Technologies, Inc. and Certain of Its Executives -
Heritage Oaks Bancorp to Present at Fig Partners 3rd Annual West Coast CEO Forum










